Magnetic nanoparticle ͑MNP͒ detection for biological and medicinal applications has been achieved by a variety of sensing schemes. The search-coil based sensing scheme is one of the good candidates among them for future point-ofcare devices and systems because of its following unique integrated features: relatively high sensitivity at room temperature, 1 dynamic volume detection ͑nonsurface binding͒, intrinsic superiority to measure ac magnetic field, functionality as an antenna for wireless information transmission, and application driven properties such as low cost, portability, and easy to use. In traditional ac magnetic susceptibility measurement such as Physical Property Measurement System, 2 DynoMag Susceptometer, 3 and Slit Toroid Device, 4 a pair of balanced coils picks up the magnetization of the sample under an ac magnetic field and a lock-in amplifier or impedance analyzer is used to detect the complex ac susceptibility. However, this method suffers from high background fluctuation due to the thermal and mechanical instability of the coils, as well as the magnetic moment contribution from sample matrix ͑e.g., water͒ and/or container ͑e.g., plastic tube͒. Given the small amount of MNPs sample in the paramagnetic or diamagnetic environment, the background is a significant portion of the overall signal. In contrast, a mixing-frequency method 5 has been used to detect the nonlinear magnetization of MNPs per testing sample by measuring the amplitude of the mixing frequency signals and thereby avoid the high noise at the fundamental frequencies. 6, 7 A magnetic field with low frequency ͑e.g., f 2 =10 Hz͒ and large amplitude drives the MNPs into their nonlinear saturation region periodically. Another magnetic field with higher frequency ͑e.g., f 1 = 20 kHz͒, and with a relatively small amplitude due to the inductance of excitation coil, is used to transfer the nonlinearity into the mixing frequency signals, such as f 1 +2f 2 ͑20.02 kHz͒. In this higher frequency region, the detection coil has higher output voltage amplitude, and the measurement system has lower 1/f noise, thus the mixing-frequency method can greatly improve the signal-to-noise ratio.
In this letter, we propose and demonstrate a search coil based susceptometry to measure the real-time Brownian relaxation of MNPs by the mixing-frequency method. In previous studies, 8, 9 the changes in Brownian relaxation before and after the binding events were experimentally shown by searching the peak of imaginary susceptibility in the entire frequency domain. This method faces a challenge for a realtime measurement. We address this challenge in this letter. Phase delay of the mixing-frequency signal is measured along the frequency of one of applied sweeping ac fields. We show that the phase delay is highly related to the relaxation time of MNPs, which enables monitoring the Brownian relaxation process of MNPs in real time.
Superparamgnetic nanoparticles with small sizes are typically being used for biological applications to avoid the aggregation as well as any negative influence without external field. Its magnetization curve can be expressed as follows:
where M S is the saturation magnetization, m 0 is the magnetic moment of a single particle, 0 is the magnetic permeability of vacuum, H is the applied field, k B is the Boltzmann constant, T is the absolute temperature, and L is the Langevin function.
Two sinusoidal magnetic fields are applied simultaneously as follows: one with low amplitude A 1 , high frequency f 1 , written as A 1 cos͑2f 1 t͒; the other with high amplitude A 2 , low frequency f 2 , written as A 2 cos͑2f 2 t͒. The sum of these two fields ͑H͒ is transferred to magnetization ͑M͒ by Langevin function. Taylor Expansion near zero magnetization shows that, besides the linear response, the major mixing components are as the following:
There are two relaxation mechanisms for MNPs. The physical rotation of particle in the viscous medium is called Brownian relaxation, and magnetic dipole flipping inside a stationary particle is called Néel relaxation. Brownian relaxation depends on an effective hydrodynamic volume. Néel relaxation depends on magnetic volume. The total relaxation process is a parallel model of these two relaxation schemes, but Brownian relaxation dominates when MNP's diameter is large, e.g., iron oxide MNP's diameter is larger than 20 nm;
where is the viscosity of the carrier or matrix fluid and V H is the effective hydrodynamic volume of MNP. When the frequency of ac applied field is low, the particles' magnetization can follow the excitation field tightly, and the susceptibility is a real number. As the excitation frequency increases, the particles' magnetization cannot follow the excitation field, and the relaxation processes introduce a phase in the complex ac susceptibility. The relationship between relaxation time and phase of ac susceptibility can be calculated using Debye model.
where 0 is the static susceptibility and is the angular frequency. Assuming the particles' magnetization has a phase delay 1 to the high frequency field and a phase delay 2 to the low frequency field, the mixing-frequency component of magnetization becomes as follows:
The total relaxation phase 1 +2 2 can therefore be determined by measuring the phase of the mixing frequency at f 1 +2f 2 . If one frequency ͑e.g., f 2 ͒ is fixed, and the other frequency ͑e.g., f 1 ͒ is swept, the relaxation phase 1 +2 2 along f 1 will show the relationship between 1 and f 1 . Either one of f 1 and f 2 can be swept depending on whether high frequency region or low frequency region is of interest.
Our search-coil based Susceptometry setup includes two excitation coils that generate 10 Hz ac field with 100 Oe amplitude and 20 kHz ac field with 10 Oe amplitude, respectively. One pair of pick up coils with differentially wounded 500 rounds is installed. An instrumentation amplifier connected to a digital acquisition card ͑DAQ͒ is used for the signal amplification. LABVIEW program for the instrument control and MATLAB program for signal processing are installed in the computer for controlling the whole setup. Three commercial iron oxide MNPs samples ͑Ocean NanoTech, Springdale, AR͒ are used for Brownian relaxation study: SHP35 ͑MNPs with 35 nm core size, 4 nm oleic acid, and amphiphilic polymer coating, 0.1 ml, 5 mg/ml in H 2 O-carboxylic acid solution͒, IPG35 ͑SHP35 conjugated with around 10 nm protein G layer, 0.1 ml, 1 mg/ml͒, and IPG35-Ab ͑IPG35 conjugated with around 10 nm Goat antiHuman IgG ͑an antibody isotype of mammals͒ HRP with ratio 1:100, 0.1 ml, 1 mg/ml͒. Particle size distributions are measured by a dynamic light scattering ͑DLS͒ instrument ͑"90 Plus Particle Sizer," Brookhaven Instruments Corp., Holtsville, NY͒ and are shown in the Fig. 1 . The DLS measurement results are consistent with the data provided by Ocean NanoTech. All the three samples are from the same batch of 35 nm iron oxide MNP core, so the wide hydrodynamic size distribution of IPG35-Ab shows that IPG35 binds with antibodies in a range of binding affinity. This is also confirmed by an independent gel electropherosis measurement ͑results not shown here͒.
We measured the MNPs' phase delay of these three samples under ac fields. Phase delay of the mixing-frequency signal is measured by scanning the frequency of f 1 up to 10 kHz. The results of 10 times average are shown in Fig. 2 . To prevent any temperature drift due to joule heating of the coil, tone bursts are applied rather than continuous ac field. The experimental results are fitted by the Debye model in Eq. ͑4͒. Since the particles are not monodispersed, the total susceptibility comes from the contributions of all MNPs with various sizes. As shown in the Fig. 2 , Debye model with the superposition of MNPs' hydrodynamic size distribution 12 is a good fit in our case, although it is argued that Debye model is only valid for small-amplitude ͑Ͻ1 kA/ m͒ ͑Ref. 13͒ low-frequency 14 applied ac field and a high frequency susceptibility ϱ is needed for the Debye fitting.
The binding process of the antibody to protein coated MNPs solution is detected by monitoring real time relaxation. Instead of the time-consuming whole frequency scan, the frequency f 1 is fixed at a 4 kHz due to the high signalto-noise ratio around this frequency region ͑detection coil is not sensitive in lower frequency region while MNP has low ac susceptibility in higher frequency region͒. 0.05 ml antibody ͑goat antihuman IgG HRP conjugated, 5 mg/ml͒ is dropped onto 0.1 ml IPG35 sample. The antibody sample will then diffuse slowly into IPG35 solution, and gradually bind to protein G on the surface of MNPs, until protein G binding sites on MNPs are saturated with antibody and has the same hydrodynamic size distribution as the standard IPG35-Ab sample prepared by the Ocean NanoTech. On the surface of IPG35 MNPs where protein G is not attached, hydrophilic polyethyleneglycol ͑PEG͒ is coated to block nonspecific binding. Both the phase transition ͑Fig. 3͒ and amplitude transition ͑not shown here͒ during protein G-antibody binding process are recorded. After the antibody is added to the sample at the 50th second, the detected amplitude of the mixing frequency is dropping sharply because the sample gets diluted ͑away from the center of the detection coil͒, and also binding events will decrease the MNPs' susceptibility ͉͉ as shown in Eq. ͑4͒. The amplitude of susceptibility has been used to determine particle clustering and binding 15 but it is heavily affected by the spatial distribution and concentration of the MNPs. In contrast, the phase information records the binding process reliably. As shown in Fig. 3 , the antibody solution is added into IPG35 solution at 50th second. As antibodies diffuse into IPG35 solution and bind with MNPs, the phase delay of magnetization then begins to increase, and gradually reaches a plateau which is very close to that of the standard IPG35-Ab. The control experiment is conducted by dropping 0.05 ml antibodies into 0.1 ml SMG35 ͑SHP35 conjugated with around 10 nm PEG layer, 1 mg/ml͒. The phase delay measurement shows very little increase because PEG out layer of SMG35 MNPs effectively blocks the nonspecific binding between MNPs and antibodies. The slight increase is possibly because of the higher viscosity from the abundant antibodies in the solution. The experimental and control results show that our system accurately detects the binding between the protein G and antibodies in real time. There are two sources for the relatively large noise for the real time phase delay measurement. Since the MNPs concentration decreases due to dilution, the output signal amplitude decreases and the phase delay measurement suffers from smaller signal-to-noise ratio. Another noise source is from the digitization device when measuring the small mixing frequency signals buried in the large carrier frequency signals. Dynamic carrier tone cancellation scheme 16 can be implemented to reduce the noise and this is in progress.
Another method to determine the binding process is to use the ratio of higher harmonics from the nonlinear magnetization. 17 The main idea is that when hydrodynamic size increases, the MNPs relax slower and are less likely to reach saturation region, thus the nonlinearity of magnetization changes. In our case, the ratio between amplitude at f 1 +2f 2 and at f 1 +4f 2 is tracked along with phase measurement during the binding process. The results of amplitude ratio are much less sensitive than the phase measurement, and the results are much harder to be interpreted into binding properties. However, the amplitude ratio of higher harmonics contains rich information of nonlinear magnetization and may complement phase measurement to study the MNPs.
In summary, we have developed a technique to detect the real-time relaxation of MNPs by using the mixing-frequency method. Correlation between the phase of the mixing frequency term and the Brownian relaxation of the MNPs was theoretically derived. Experimentally three MNPs ͑SHP35, IPG35, and IPG35-Ab͒ have been measured, and the results were fitted by Debye model with the consideration of MNPs size distribution. Real-time measurement of binding process between MNP-labeled protein G and antibody was demonstrated along with a control experiment. This study shows the potential capability of the developed technique for fundamental biological research, disease diagnostic and drug discovery.
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